The release profile was determined using a dissolution test.
The floating property was also observed during the dissolution test.
The tablets were investigated by the in vitro dissolution test.
A common/standardized dissolution test method would benefit formulators for development purposes.
The dissolution test showed that LOV-RNs had a higher dissolution rate than LOV-SNs.
Dissolution test was carried out in media with different pH (1.2, 6.5, 6.8 and 7.2).
The dissolution test was performed according to the USP paddle method in intestinal fluid (pH 6.8).
A principle method development consideration must be how to reproducibly present the particles to the dissolution test apparatus.
Dissolution test methods are currently non-standardized for inhaled drugs and are not intended to provide IVIVC correlations.
The regression model of salt dissolution with time was obtained through soaking dissolution test.
The considered factors mainly influencing the dissolution test results were pH and volume of dissolution medium, and paddle stirring speed.
